REFERENCES
- Miserocchi E, Baltatzis S, Foster C S. Ocular features associated with anticardiolipin antibodies: a descriptive study. Am J Ophthalmol. 2001; 131: 451–456, [PUBMED], [INFOTRIEVE], [CSA]
- Roubery R AS. Immunology of the antiphospholipid antibody syndrome. Arthritis Rheum. 1996; 39: 1444–1454, [CSA]
- Hughes G RV. The antiphospholipid syndrome: ten years on. Lancet. 1993; 342: 341–344, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Love P E, Santoro S A. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Ann Intern Med. 1990; 112: 682–698, [PUBMED], [INFOTRIEVE], [CSA]
- Sammaritano L R, Gharavi A E, Lockshin M D. Antiphospholipid antibody syndrome: immunologic and clinical aspects. Semin Arthritis Rheum. 1990; 20: 81–96, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Harris E N, Gharavi A E, Loizou S. Crossreactivity of antiphospholipid antibodies. J Clin Lab Immunol. 1985; 16: 1–6, [PUBMED], [INFOTRIEVE], [CSA]
- Zarrabi M H, Zucker S, Miller F. Immunologic and coagulation disorders in chlorpromazine-treated patients. Ann Intern Med. 1979; 91: 194–199, [PUBMED], [INFOTRIEVE], [CSA]
- Miserocchi E, Foster C S. Antiphospholipid syndrome. Diagnosis and treatment of uveitis, CS Foster, AT Vitale. WB Saunders, Philadelphia 2001; 683–692
- Bolling J P, Brown G C. The antiphospholipid antibody syndrome. Curr Opin Ophthalmol. 2000; 11: 211–213, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Cobo-Soriano R, Sanchez-Ramon S, Aparicio M J. Antiphospholipid antibodies and retinal thrombosis in patients without risk factors: a prospective case-control study. Am J Ophthalmol. 1999; 128: 725–732, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lockwood C J, Romero R, Feinberg R F. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. Am J Obstet Gynecol. 1989; 161: 369–373, [PUBMED], [INFOTRIEVE], [CSA]
- Kalunian K C, Peter J B, Middlekauff H R. Clinical significance of a single test for anti-cardiolipin antibodies in patients with systemic lupus erythematosus. Am J Med. 1988; 85: 602–608, [PUBMED], [INFOTRIEVE], [CSA]
- Fort J G, Cowchock F S, Abruzzo J L, Smith J B. Anticardiolipin antibodies in patients with rheumatic diseases. Arthritis Rheum. 1987; 30: 752–760, [PUBMED], [INFOTRIEVE], [CSA]
- Glacet-Bernard A, Bayarni N, Chretien P. Antiphospholipid in retinal vascular occlusion. Arch Ophthalmol. 1994; 112: 790–795, [PUBMED], [INFOTRIEVE], [CSA]
- Dori D, Gelfand Y A, Brenner B, Miller B. Cilioretinal artery occlusion: an ocular complication of primary antiphospholipid syndrome. Retina 1997; 17: 555–557, [PUBMED], [INFOTRIEVE], [CSA]
- Levine S R, Welch K M. The spectrum of neurologic disease associated with antiphospholipid antibodies. Arch Neurol. 1987; 44: 876–883, [PUBMED], [INFOTRIEVE], [CSA]
- Khamashta M A, Cervera R, Asherson R A. Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet. 1990; 335: 1541–1544, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Asherson R A, Mackworth-Young C G, Boey M L. Pulmonary hypertension in systemic lupus erythematosus. Br Med J (Clin Res Ed). 1983; 287: 1024–1025, [CSA]
- Hamsten A, Norberg R, Bjorkholm M. Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events. Lancet. 1986; 1: 113–116, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Asherson R A, Morgan S H, Harris E N. Arterial occlusion causing large bowel infarction - a reflection of clotting diathesis in SLE. Clin Rheumatol. 1986; 5: 102–106, [PUBMED], [INFOTRIEVE], [CSA]
- Pelletier S, Landi B, Piette J C. Antiphospholipid syndrome as the second cause of non-tumorous Budd-Chiari syndrome. J Hepatol. 1994; 21: 76–80, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hughes G RV. Connective tissue disease and skin. Clin Exp Dermatol. 1984; 9: 535–544, [PUBMED], [INFOTRIEVE], [CSA]
- Giorgio D, Balacco Gabrieli C, Bonomo L. The clinico-ophthalmological spectrum of antiphospholipid syndrome. Ocul Immunol Inflamm. 1998; 6: 269–273, [CROSSREF], [CSA]
- Castanon C, Amigo M C, Banales J L. Ocular vaso-occlusive disease in primary antiphospholipid syndrome. Ophthalmology. 1995; 102: 256–262, [PUBMED], [INFOTRIEVE], [CSA]
- Wiechens B, Schroder J O, Potzsch B, Rochels R. Primary antiphospholipid antibody syndrome and retinal occlusive vasculopathy. Am J Ophthalmol. 1997; 123: 848–850, [PUBMED], [INFOTRIEVE], [CSA]
- Boey M L, Colaco C B, Gharavi A E. Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant. Br Med J (Clin Res Ed). 1983; 287: 1021–1023, [CSA]
- Jonas J, Kolble K, Volcker H E, Kalden J R. Central retinal artery occlusion in Sneddon's disease associated with antiphospholipid antibodies. Am J Ophthalmol. 1986; 102: 37–40, [PUBMED], [INFOTRIEVE], [CSA]
- Levine S R, Crofts J W, Lesser G R. Visual symptoms associated with the presence of a lupus anticoagulant. Ophthalmology. 1988; 95: 686–692, [PUBMED], [INFOTRIEVE], [CSA]
- Ang L P, Yap E Y, Fam H B. Bilateral choroidal infarction in a patient with antiphospholipid syndrome: a case report. Clin Exp Ophthalmol. 2000; 28: 326–328, [CROSSREF], [CSA]
- Hartnett M E, Laposata M, Van Cott E. Antiphospholipid antibody syndrome in a six-year-old female patient. Am J Ophthalmol. 2003; 135: 542–544, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Aguilar F C, Cuesta L J. Antiphospholipid antibodies in asymptomatic pediatric patients. An Esp Pediatr. 2001; 54: 444–449, [CSA]
- Demirci F Y, Kucukkaya R, Akarcay K. Ocular involvement in primary antiphospholipid syndrome. Ocular involvement in primary APS. Int Ophthalmol. 1998; 22: 323–329, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Wiechens B, Schroder J O, Potzsch B, Rochels R. Primary antiphospholipid antibody syndrome and retinal occlusive vasculopathy. Am J Ophthalmol. 1997; 123: 848–850, [PUBMED], [INFOTRIEVE], [CSA]
- Hsiao Y C, Jou J R, Lin S Y, Lin S L. Primary antiphospholipid syndrome manifested as venous stasis retinopathy. Zhonghua Yi Xue Za Zhi (Taipei). 2000; 63: 498–502, [INFOTRIEVE], [CSA]
- Giorgi D, Gabrieli C B, Bonomo L. The clinico-ophthalmological spectrum of antiphospholipid syndrome. Ocul Immunol Inflamm. 1998; 6: 269–273, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Gerber S L, Cantor L B. Progressive optic atrophy and the primary antiphospholipid antibody syndrome. Am J Ophthalmol. 1990; 110: 443–444, [PUBMED], [INFOTRIEVE], [CSA]
- Harada T, Ohashi T, Fukazawa T. Visual function in patients with optic neuritis associated with acute transverse myelopathy in multiple sclerosis. Jpn J Ophthalmol. 1995; 39: 290–294, [PUBMED], [INFOTRIEVE], [CSA]
- Guglielmone H A, Fernandez E J. Distribution of lupus anticoagulant and anticardiolipin antibody isotypes in a population with antiphospholipid syndrome. J Rheumatol. 1999; 26: 86–90, [PUBMED], [INFOTRIEVE], [CSA]
- Lozier J, Takahashi N, Putnam F W. Complete amino acid sequence of human plasma beta 2-glycoprotein. I. Proc Natl Acad Sci USA. 1984; 81: 3640–3644, [PUBMED], [INFOTRIEVE], [CSA]
- Simantov R, LaSala J M, Lo S K. Activation of cultured vascular endothelial cells by antiphospholipid antibodies. J Clin Invest. 1995; 96: 2211–2219, [PUBMED], [INFOTRIEVE], [CSA]
- Galli M, Comfurius P, Maassen C. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet. 1990; 335: 1544–1547, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Petri M. Pathogenesis and treatment of the antiphospholipid antibody syndrome. Med Clin North Am. 1997; 81: 151–177, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Carreras L O, Maclouf J. Antiphospholipid antibodies and eicosanoids. Lupus. 1994; 3: 271–273, [PUBMED], [INFOTRIEVE], [CSA]
- Del Papa N, Guidali L, Spatola L, Bonara P, Borghi M O, Tincani A, Balestrieri G, Meroni P L. Relationship between antiphospholipid and anti-endothelial cell antibodies. III. Beta 2 glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules. Clin Exp Rheumatol. 1995; 13: 179–185, [PUBMED], [INFOTRIEVE], [CSA]
- Lockshin M D. Pregnancy loss in the antiphospholipid syndrome. Thromb Haemost. 1999; 82: 641–648, [PUBMED], [INFOTRIEVE], [CSA]
- Brandt J T, Triplett D A, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardization Committee of the ISTH. Thromb Haemost. 1995; 74: 1185–1190, [PUBMED], [INFOTRIEVE], [CSA]
- Wilson W A, Gharavi A E, Piette J C. International classification criteria for antiphospholipid syndrome: synopsis of a post-conference workshop held at the Ninth International (Tours) aPL Symposium. Lupus. 2001; 10: 457–460, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Finazzi G, Brancaccio V, Moia M. Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry. Am J Med. 1996; 100: 530–536, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Goel N. Antiphospholipid antibody syndrome: current concepts. Hosp Pract (Off Ed). 1998; 33: 129–130, [CSA]
- Kleiner R C, Najarian L V, Schatten S. Vaso-occlusive retinopathy associated with antiphospholipid antibodies (lupus anticoagulant retinopathy). Ophthalmology. 1989; 96: 896–904, [PUBMED], [INFOTRIEVE], [CSA]
- Ingram S B, Goodnight S H, Jr, Bennett R M. An unusual syndrome of a devastating noninflammatory vasculopathy associated with anticardiolipin antibodies: report of two cases. Arthritis Rheum. 1987; 30: 1167–1172, [PUBMED], [INFOTRIEVE], [CSA]
- Rosove M H, Brewer P M. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med. 1992; 117: 303–308, [PUBMED], [INFOTRIEVE], [CSA]
- Khamashta M A, Cuadrado M J, Mujic F. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med. 1995; 332: 993–997, [PUBMED], [INFOTRIEVE], [CSA]